{"id":"https://genegraph.clinicalgenome.org/r/82d552e4-16da-4748-9238-9bf55e0a2ebdv1.0","type":"EvidenceStrengthAssertion","dc:description":"*SH2D1A* was reported as the gene associated with X-linked lymphoproliferative syndrome in 1998 simultaneously by three different groups (PMID 9811875, 9771704, 9774102). First described clinically in 1975 (PMID 48119), X-linked lymphoproliferative disease due to *SH2D1A* deficiency (known as XLP1) is characterised as one of fulminant infectious mononucleosis, lymphoproliferative disorders or dysgammaglobulinaemia, generally developing after first exposure to EBV. Patients may have other autoimmune features such as aplastic anaemia, vasculitis and colitis. Since the discovery of the *SH2D1A* gene, many genetic variants spanning the length of the gene have been described in affected patients, including large deletions, splice-site mutations, nonsense and missense mutations (see PMID 11049992 for a description of 35 families with at least two affected individuals in each family). The mechanism is known to be loss of function. Included in this curation are 6 variants reaching the maximum scorable genetic evidence (PMID 11049992, PMID 9811875, PMID 9774102, PMID11159547, PMID 23829589, PMID 20632414). This gene-disease association is supported by experimental evidence, including animal models, expression studies and gene transfer rescue studies (PMID 12966553, 9774102, 29705247). *SH2D1A *encodes of SAP, a protein basally expressed in NK and T cells (PMID 9774102), and interacts with SLAM and other members of the CD2 subfamily of cellular receptors (PMID 15661030 for summary). Deletion of exon 2 of the sap gene in mice recapitulates the phenotype seen in humans with absence of SAP protein, susceptibility to murine gammaherpesvirus-68 and dysgammaglobulinaemia (PMID 12966553). Transduction of wildtype *SH2D1A* in patient T-cells with a lentiviral vector restores SAP expression and rescues defective T-follicular helper cell function and cytotoxicity (PMID 29705247). HSCT is a curative option in patients with XLP1, and lentiviral gene therapy has shown promising results in both murine models and patient cells (PMID 30459818, PMID 39309261, PMID 23223356). Taken together, the association between *SH2D1A* and X-linked lymphoproliferative disease due to *SH2D1A* deficiency is definitive.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/82d552e4-16da-4748-9238-9bf55e0a2ebd","GCISnapshot":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10145","date":"2025-10-14T02:30:00.357Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10145","date":"2025-10-14T01:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6e56db7-2401-48c2-a9dc-a7f97f182e90","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc835c96-fd40-4862-9951-e30edb03f8da","type":"Finding","dc:description":"Absence SAP protein confirmed by western blot\nNormal baseline lymphocytes\nDisseminated and prolonged lymphocytic infiltration of lungs and liver after exposure to murine gammaherpesvirus-68 (similar to EBV)\nDysgammaglobulinaemia in particularly post gammaherpesvirus-68 infection","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12966553","rdfs:label":"sap deficient mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5ab6f0f3-6624-431f-a270-770f35f4d578","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c0cf0223-05b0-4372-ab40-687f09c41432","type":"Finding","dc:description":"Rescue of SAP expression T cells\nFunctional correction of T follicular helper cells in vitro with correction of immunoglobulin production\nRescue of ability to kill EBV-infected LCLs as demonstrated through chromium release assay","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29705247","rdfs:label":"SAP transduction in patient cells rescues function","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/69f8900b-8d07-4b73-aae2-51f61bea4dc3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c37f9458-e628-43b1-9a58-5e26501c257a","type":"Finding","dc:description":"SH2D1A is expressed in spleen, thymus and PBL as demonstrated by Northern blot analysis of mRNAs using a radiolabelled human SAP-specific cDNA probe. (Figure 3a)\n\nSH2D1A is expressed in T cells including immature and mature populations. SH2D1A is mainly absent in B cells, with the exception of some lymphoma cell lines (Raji EBV+ lymphoma line) (Figure 3b and c).  \n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9774102","rdfs:label":"SAP expression by Northern blot analysis","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b2b0bce-21ac-4204-bed1-b9ec2c23f922","type":"EvidenceLine","dc:description":"Not predicted to lead to nonsense mediated decay but does result in premature stop\nFunctional evidence demonstrating lack of protein expression","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b2b0bce-21ac-4204-bed1-b9ec2c23f922_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Absence of SAP expression in patient cells","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2b2b0bce-21ac-4204-bed1-b9ec2c23f922_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20632414","allele":{"id":"https://genegraph.clinicalgenome.org/r/2ad38856-81b7-4220-9d8f-8dc51bebe0d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002351.5(SH2D1A):c.245dup (p.Asn82LysfsTer22)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573159233"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d58c0898-40aa-4bcf-af29-57f10c40ced4","type":"EvidenceLine","dc:description":"Weak functional evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d58c0898-40aa-4bcf-af29-57f10c40ced4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Truncated gene product visualised on gel","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d58c0898-40aa-4bcf-af29-57f10c40ced4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a45b16e-1b80-46ac-9c9f-6dc07124b056","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.11:g.124365765_124365828del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3246685719"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7b0ee5e5-869c-49bb-9232-ee524e9f3178","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b0ee5e5-869c-49bb-9232-ee524e9f3178_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9811875","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d0461ca-c7b2-4f9f-978f-0ddfbdc74a58","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002351.5(SH2D1A):c.163C>T (p.Arg55Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA255589"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a62b4fa3-3edf-4d12-b5d8-b8114d0510b7","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a62b4fa3-3edf-4d12-b5d8-b8114d0510b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9811875","allele":{"id":"https://genegraph.clinicalgenome.org/r/317f9287-8706-4351-9591-51354d3d71ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002351.5(SH2D1A):c.172C>T (p.Gln58Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA255592"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/83262b67-1108-4fa5-8253-18d772fd20b0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83262b67-1108-4fa5-8253-18d772fd20b0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Extremely short half-life as per PMID 11477068\nCOS-7 cells transiently transfected with mutant SAP cDNA a metabolically labelled with 35s-methionine and 35s-cysteine. Then cultured with cycloheximide for various time intervals. This mutation resulted in a very short half-life with almost no product remaining after 3 hours (cf 20 hours for wildtype)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/83262b67-1108-4fa5-8253-18d772fd20b0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","allele":{"id":"https://genegraph.clinicalgenome.org/r/f73ea495-401a-4533-a19b-75d5943c7827","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002351.5(SH2D1A):c.20A>G (p.Tyr7Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414122199"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/db234eb6-d55a-4def-9c7e-e59c03f22f24","type":"EvidenceLine","dc:description":"Functional data not strong","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db234eb6-d55a-4def-9c7e-e59c03f22f24_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Gel visualisation of mRNA PCR product shows loss of exon 2 coding in most transcripts","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/db234eb6-d55a-4def-9c7e-e59c03f22f24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9774102","allele":{"id":"https://genegraph.clinicalgenome.org/r/8904ca6d-da43-498e-9050-1473bb2fb272","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002351.5(SH2D1A):c.138-3C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658824028"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ab624295-900f-41c9-b4b2-6dbb6cc2ebed","type":"EvidenceLine","dc:description":"Weak functional evidence","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab624295-900f-41c9-b4b2-6dbb6cc2ebed_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"No detected product of exon 1 using PCR","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ab624295-900f-41c9-b4b2-6dbb6cc2ebed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11159547","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4366a57-8790-46d4-852f-600a85207304","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.10:g.(?_123480147)_(123480649_?)del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1076142"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/84424550-05f1-438f-92d4-86ec7437a41c_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59882abb-e626-4d94-99e0-941abd7265d8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K046","family":{"id":"https://genegraph.clinicalgenome.org/r/59882abb-e626-4d94-99e0-941abd7265d8","type":"Family","rdfs:label":"K046","member":{"id":"https://genegraph.clinicalgenome.org/r/8320a319-4993-46a8-81c4-def77752ecb7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K046 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/f73ea495-401a-4533-a19b-75d5943c7827"},"detectionMethod":"Targeted sequencing of SH2D1A","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001915","obo:HP_0031693"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/83262b67-1108-4fa5-8253-18d772fd20b0_variant_evidence_item"}}},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0031693","obo:HP_0001915"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8320a319-4993-46a8-81c4-def77752ecb7"}},{"id":"https://genegraph.clinicalgenome.org/r/c15f9479-b6fb-4d83-80eb-eaddf4550fdc_proband_segregation","type":"FamilyCosegregation","dc:description":"Unclear who in family has been genotyped","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K054","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/c15f9479-b6fb-4d83-80eb-eaddf4550fdc","type":"Family","rdfs:label":"K054","member":{"id":"https://genegraph.clinicalgenome.org/r/fd3b1b08-0670-416b-baec-91da59e097a4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K 054 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3619db18-3b5b-4ef7-a721-6cbb465ed422","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002351.5(SH2D1A):c.191G>A (p.Trp64Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10509271"}},"detectionMethod":"Targeted sequencing of SH2D1A","firstTestingMethod":"PCR","phenotypes":["obo:HP_0005523","obo:HP_0002961","obo:HP_0031693"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d4ae407b-74f0-49e4-9843-4f0467dd6c24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","allele":{"id":"https://genegraph.clinicalgenome.org/r/3619db18-3b5b-4ef7-a721-6cbb465ed422"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0031693","obo:HP_0005523","obo:HP_0002961"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fd3b1b08-0670-416b-baec-91da59e097a4"}},{"id":"https://genegraph.clinicalgenome.org/r/716bdd26-a41d-4c68-94b3-9bbfce950c86_proband_segregation","type":"FamilyCosegregation","dc:description":"Clinical diagnosis of XLP based on family history and symptoms","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K055","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/716bdd26-a41d-4c68-94b3-9bbfce950c86","type":"Family","rdfs:label":"K055","member":{"id":"https://genegraph.clinicalgenome.org/r/f9ddedac-bc7e-40dc-946f-988a310de964","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K055 9","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a45b16e-1b80-46ac-9c9f-6dc07124b056"},"detectionMethod":"Targeted sequencing of SH2D1A gene","firstTestingMethod":"PCR","phenotypes":["obo:HP_0005523","obo:HP_0001915","obo:HP_0002961","obo:HP_0031693"],"previousTesting":true,"previousTestingDescription":"RFLP linkage analysis studies","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d58c0898-40aa-4bcf-af29-57f10c40ced4_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0002961","obo:HP_0005523","obo:HP_0031693","obo:HP_0001915"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f9ddedac-bc7e-40dc-946f-988a310de964"}},{"id":"https://genegraph.clinicalgenome.org/r/7c39895c-dc5a-4023-b5c6-8d537ab36979_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K053","family":{"id":"https://genegraph.clinicalgenome.org/r/7c39895c-dc5a-4023-b5c6-8d537ab36979","type":"Family","rdfs:label":"K053","member":{"id":"https://genegraph.clinicalgenome.org/r/9d9bffaf-768e-4133-b196-bccb7015b485","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K053 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/320e7a9b-d803-4cc8-b208-9db6ea66af56","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002351.5(SH2D1A):c.158C>T (p.Thr53Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414123480"}},"detectionMethod":"Targeted sequencing of SH2D1A gene","firstTestingMethod":"PCR","phenotypes":["obo:HP_0031693","obo:HP_0002665","obo:HP_0002961"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/478cc0c4-7a92-4f4f-ab44-69bd67a3eaee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","allele":{"id":"https://genegraph.clinicalgenome.org/r/320e7a9b-d803-4cc8-b208-9db6ea66af56"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"phenotypePositiveAllelePositive":14,"phenotypes":["obo:HP_0002665","obo:HP_0031693","obo:HP_0002961"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9d9bffaf-768e-4133-b196-bccb7015b485"}},{"id":"https://genegraph.clinicalgenome.org/r/b39a13c9-de6c-4f5f-a786-bf39ce103267_family_segregation","type":"FamilyCosegregation","dc:description":"Unclear who in family has been genotyped","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K004","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/b39a13c9-de6c-4f5f-a786-bf39ce103267","type":"Family","rdfs:label":"K004"},"meetsInclusionCriteria":false,"phenotypeFreeText":"FIM, lymphoma, dysgammaglobulinaemia","phenotypePositiveAllelePositive":6},{"id":"https://genegraph.clinicalgenome.org/r/566b7c3f-5089-42fc-804c-7c97564abd80_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11049992","rdfs:label":"K006","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/566b7c3f-5089-42fc-804c-7c97564abd80","type":"Family","rdfs:label":"K006"},"meetsInclusionCriteria":false,"phenotypeFreeText":"FIM, LPD","phenotypePositiveAllelePositive":6}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d4ae407b-74f0-49e4-9843-4f0467dd6c24","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4ae407b-74f0-49e4-9843-4f0467dd6c24_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/eb28fa31-d12b-46f8-a482-a79d575d51bb","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb28fa31-d12b-46f8-a482-a79d575d51bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23829589","allele":{"id":"https://genegraph.clinicalgenome.org/r/e68df756-f909-4653-9ee9-367af9a45022","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000023.10:g.(?_123480493)_(123505241_?)del","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1459977"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/478cc0c4-7a92-4f4f-ab44-69bd67a3eaee","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/478cc0c4-7a92-4f4f-ab44-69bd67a3eaee_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":" Selectively disrupts binding to the non-phosphorylated form of the CD150 Tyr281 peptide. Also disrupts binding of CD244, CD84 and CD229 as per PMID 11477068","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/478cc0c4-7a92-4f4f-ab44-69bd67a3eaee_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":12005,"specifiedBy":"GeneValidityCriteria11","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Juj9UixtqMs","type":"GeneValidityProposition","disease":"obo:MONDO_0024551","gene":"hgnc:10820","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_84424550-05f1-438f-92d4-86ec7437a41c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}